以手術計分法預測卵巢癌術後併發症

Development of Risk Score to Predict Postoperative Complication for Ovarian Cancer

卵巢癌的治療需要積極的減積手術後，再予以鉑為主的化學治療，但廣泛的手術會產生許多併發症，因此在實施積極性減積手術，和術後可能引發可致死的併發症間，需取得一平衡點。對影響預後的因素，如患者的年齡、肥胖、和有其它內科疾病者，更要特別小心，因為這些患者預後多欠佳。最近有些作者發展出一些臨床上危險性的評分，如外科複雜性計分和外科Apgar氏計分，先找出術後易發生併發症的因子，當危險因子或分數很低，便可加強治療，反之，則應以保守減少併發症和死亡率。

Treatment of advanced stages of ovarian cancer typically consists of upfront aggressive surgical cytoreduction combined with adjuvant platinum-based chemotherapy. There is necessary a balance between survival benefit derived from aggressive cytoreduction and risk of serious perioperative morbidity and mortality associated with factors such as patient’s age, body weight and overall medical condition. Some authors desire to develop a clinical risk scoring system using best predictors, such as the surgical complexity score and surgical Apgar score. The risk of complications are substantial for the patients with low score. There, risk stratification should be used to help plan perioperative care and consider optimal treatment planning.